Resultados da pesquisa por Autor

1

IMMU-02. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT: A NEW DIRECTION FOR CHECKPOINT IMMUNOTHERAPY

IMMU-02. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT: A NEW DIRECTION FOR CHECKPOINT IMMUNOTHERAPY

Por Ampudia-Mesias, Elisabet, Moertel, Christopher, Olin, Michael
Publicado no Neuro Oncol (2017)

Obter o texto integral
Obter o texto integral

Artigo

2

IMMU-14. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT

IMMU-14. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT

Por Ampudia-Mesias, Elisabet, Moertel, Christopher, Pluhar, Elizabeth, Olin, Michael
Publicado no Neuro Oncol (2017)

Obter o texto integral
Obter o texto integral

Artigo

3

IMMU-11. TARGETING THE CD200 CHECKPOINT BLOCKADE: A NEW DIRECTION FOR IMMUNOTHERAPY

IMMU-11. TARGETING THE CD200 CHECKPOINT BLOCKADE: A NEW DIRECTION FOR IMMUNOTHERAPY

Por Olin, Michael, Ampudia-Mesias, Elisabet, Xiong, Zhengming, Pluhar, Elizabeth, Moertel, Christopher
Publicado no Neuro Oncol (2017)

Obter o texto integral
Obter o texto integral

Artigo

4

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy

Por Xiong, Zhengming, Ampudia-Mesias, Elisabet, Shaver, Rob, Horbinski, Craig M, Moertel, Christopher L, Olin, Michael R
Publicado no Immunotherapy (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo